GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » National Health Investors Inc (NYSE:NHI) » Definitions » EBITDA per Share

National Health Investors (National Health Investors) EBITDA per Share

: $5.99 (TTM As of Dec. 2023)
View and export this data going back to 1991. Start your Free Trial

National Health Investors's EBITDA per Share for the three months ended in Dec. 2023 was $1.45. Its EBITDA per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $5.99.

During the past 12 months, the average EBITDA per Share Growth Rate of National Health Investors was 50.20% per year. During the past 3 years, the average EBITDA per Share Growth Rate was -5.60% per year. During the past 5 years, the average EBITDA per Share Growth Rate was -6.10% per year. During the past 10 years, the average EBITDA per Share Growth Rate was 0.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for National Health Investors's EBITDA per Share or its related term are showing as below:

NHI' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -42.3   Med: 0.8   Max: 65.6
Current: -5.6

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of National Health Investors was 65.60% per year. The lowest was -42.30% per year. And the median was 0.80% per year.

NHI's 3-Year EBITDA Growth Rate is ranked worse than
74.37% of 476 companies
in the REITs industry
Industry Median: 5.15 vs NHI: -5.60

National Health Investors's EBITDA for the three months ended in Dec. 2023 was $63.0 Mil.

During the past 12 months, the average EBITDA Growth Rate of National Health Investors was 45.40% per year. During the past 3 years, the average EBITDA Growth Rate was -6.50% per year. During the past 5 years, the average EBITDA Growth Rate was -5.40% per year. During the past 10 years, the average EBITDA Growth Rate was 4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of National Health Investors was 101.20% per year. The lowest was -41.60% per year. And the median was 4.25% per year.


National Health Investors EBITDA per Share Historical Data

The historical data trend for National Health Investors's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Health Investors Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA per Share
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.65 7.11 5.27 3.99 5.99

National Health Investors Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBITDA per Share Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 1.50 1.63 1.40 1.45

National Health Investors EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

National Health Investors's EBITDA per Share for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA per Share(A: Dec. 2023 )
=EBITDA/Shares Outstanding (Diluted Average)
=259.943/43.389
=5.99

National Health Investors's EBITDA per Share for the quarter that ended in Dec. 2023 is calculated as

EBITDA per Share(Q: Dec. 2023 )
=EBITDA/Shares Outstanding (Diluted Average)
=63.041/43.389
=1.45

EBITDA per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


National Health Investors  (NYSE:NHI) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


National Health Investors EBITDA per Share Related Terms

Thank you for viewing the detailed overview of National Health Investors's EBITDA per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


National Health Investors (National Health Investors) Business Description

Traded in Other Exchanges
Address
222 Robert Rose Drive, Murfreesboro, TN, USA, 37129
National Health Investors Inc is a housing and medical facility REIT. The company operate through two reportable segments i.e. Real Estate Investments and Senior Housing Operating Portfolio. Real Estate Investments segment consists of real estate investments and lease, mortgage and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and a hospital. SHOP segment is comprised of two ventures that own the operations of independent living facilities. Company's revenues are derived from rental income, mortgage and other notes receivable interest income and resident fees and services.
Executives
James R Jobe director 707 REGAL DRIVE, MURFREESBORO TN 37129
Robert G Adams director, officer: President P.O. BOX 1398, MURFREESBORO TN 37133-1398
Colden Tracy M J director C/O PLAYA HOTELS & RESORTS N.V.,, 3950 UNIVERSITY DRIVE, SUITE 301, FAIRFAX VA 22030
Robert T Webb director PO BOX 1102, MURFREESBORO TN 37133-1102
D. Eric Mendelsohn officer: EVP - Corporate Finance C/O EMERITUS CORPORATION, 3131 ELLIOTT AVENUE, SUITE 500, SEATTLE WA 98121
Mccabe Robert A Jr director 500 CHURCH ST, STE 200, NASHVILLE TN 37219
David L Travis officer: SVP/Chief Accounting Officer C/O MEDEQUITIES REALTY TRUST, 3100 WEST END AVENUE, SUITE 1000, NASHVILLE TN 37203
W Andrew Adams director, officer: President P.O. BOX 1398, MURFREESBORO TN 37133-1398
Kevin Carlton Pascoe officer: EVP - Investments 222 ROBERT ROSE DRIVE, MURFREESBORO TN 37129
Ronald V Reel officer: Chief Accounting Officer 222 ROBERT ROSE DRIVE, MURFREESBORO TN 37129
Kristin Sallee Gaines officer: Chief Credit Officer 2320 LONDONDERRY DRIVE, MURFREESBORO TN 37129
John L Spaid officer: Exec. VP of Finance 222 ROBERT ROSE DRIVE, MURFREESBORO TN 37129
Roger R Hopkins officer: Chief Accounting Officer 2930 PRINCETON LANE, MURFREESBORO TN 37129
James Justin Hutchens officer: President and COO C/O VENTAS, INC., 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Ted H Welch director PO BOX 1102, MURFREESBORO TN 37133-1102